NEWSAR
Multi-perspective news intelligence
Dark
Newsar
INTEL
News
Stories
Entities
Markets
Map
Graph
Sources
About
Search
Admin
CB
Chimagen Biosciences
Organization
Company
Mentions:
0
7 Days:
0
Recent Coverage
GSK licenses Chinese firm’s cancer drug in US$750 million deal
September 16, 2026
Related
T-cell engager
topic
•
1 co-mentions
China
location
•
1 co-mentions
Chengdu
location
•
1 co-mentions
blood cancer
topic
•
1 co-mentions
multiple myeloma
topic
•
1 co-mentions
cancer drug
topic
•
1 co-mentions
GSK
organization
•
1 co-mentions
biotechnology
topic
•
1 co-mentions